Przegla̜d Gastroenterologiczny最新文献_第4页

The role of deep learning in diagnosing colorectal cancer. 深度学习在癌症诊断中的作用。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 Epub Date: 2023-07-17 DOI: 10.5114/pg.2023.129494

Dimitrios Bousis, Georgios-Ioannis Verras, Konstantinos Bouchagier, Andreas Antzoulas, Ioannis Panagiotopoulos, Anastasia Katinioti, Dimitrios Kehagias, Charalampos Kaplanis, Konstantinos Kotis, Christos-Nikolaos Anagnostopoulos, Francesk Mulita

引用次数: 4

Appleby technique: review of the state of the art 阿普尔比技术:对最新技术的回顾

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.129502

D. Coco, S. Leanza

引用次数: 0

Biological markers of disease activity in inflammatory bowel diseases. 炎症性肠病疾病活动性的生物学标志物。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.129412

Edyta Szymanska, Sylwia Szymanska, Maciej Dadalski, Jaroslaw Kierkus

引用次数: 0

Type B aortic dissection atypically presenting as chronic abdominal pain. B型主动脉夹层非典型表现为慢性腹痛。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.129417

Rafał Filip, Wiesław Guz

引用次数: 0

Splenic artery embolization for the treatment of pancreatic portal hypertension complicated by gastric variceal haemorrhage. 脾动脉栓塞治疗胰门脉高压合并胃静脉曲张出血。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2022.121829

Min Ai, DaZhi Gao, GuangMing Lu, Jian Xu

引用次数: 0

Causes of death after liver transplantation among patients with solitary hepatocellular carcinoma in the United State, from 2004 to 2015. 2004年至2015年美国孤立性肝细胞癌患者肝移植后死亡原因

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.126045

Anas Elgenidy, Ahmed M Afifi

{"title":"Causes of death after liver transplantation among patients with solitary hepatocellular carcinoma in the United State, from 2004 to 2015.","authors":"Anas Elgenidy, Ahmed M Afifi","doi":"10.5114/pg.2023.126045","DOIUrl":"https://doi.org/10.5114/pg.2023.126045","url":null,"abstract":"Liver transplantation has gained broad acceptance as a therapeutic modality for hepatocellular carcinoma (HCC), with better overall survival than liver resection [1]. The United Network for Organ Sharing (UNOS) adopted Milan criteria for liver transplantation in patients with HCC (single lesion, diameter ≤ 50 mm, without vascular invasion, and with no metastasis) to improve survival [2]. Yang et al. reported that the median overall survival is 5.75 years after transplantation for patients meeting UNOS criteria [1]. So, even though choosing these criteria is a focal point, there is another important topic, i.e. knowing the causes of death after selecting these criteria. However, the causes of death are unclear. We used Surveillance, Epidemiology, and End Results (seer)*stat software, latest version 8.3.9.2 in our study to access SEER plus data, 18 registries [3, 4]. We identified the solitary HCC diagnosis with the primary site labelled C22.0, specific ICD-O-3 hist/behave (8170/3 – 8175/3) and concerning UNOS criteria (CS extension 2004–2015). We evaluated causes of death (ICD-10 identifications) and calculated the standardized mortality ratio (SMR), which represents the number of observed deaths from a specific cause to the number that would be expected to die over a given period. Therefore, understanding the distribution of different causes of death after liver transplantation among HCC patients is helpful in counselling patients regarding their care and survivorship. We reviewed 1260 US patients with solitary HCC who had undergone liver transplants during the period 2004–2015 (Figure 1). Most patients were aged between 45 and 79 years (1204; 95.6%), were white (1002; 79.5), male (960; 76%), married (805; 63.9%), and with a localized stage (1227; 97.4%). Of the included patients 400 (31.7%) died during this period, with a mean age","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"18 1","pages":"132-134"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/40/PG-18-50390.PMC10050984.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9595483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Current perspective and review of literature on robotic gastrectomy and oncological outcomes 机器人胃切除术和肿瘤预后的研究现状及文献综述

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.124148

D. Coco, S. Leanza

引用次数: 0

Personalized medicine in biomarker identification at their optimal cut-off selection. 在生物标记物最佳临界值选择中进行个性化医疗识别。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 Epub Date: 2022-10-18 DOI: 10.5114/pg.2022.120441

Tadeusz J Lewandowski

{"title":"Personalized medicine in biomarker identification at their optimal cut-off selection.","authors":"Tadeusz J Lewandowski","doi":"10.5114/pg.2022.120441","DOIUrl":"10.5114/pg.2022.120441","url":null,"abstract":"Introduction: Retrospective exploratory analysis to identify biomarker pairs in the AVAGAST Phase III study.Aim: The main hypothesis of this retrospective exploratory biomarker analysis is the identification of dichotomization levels based on optimal selection driven by the predictive value of single biomarkers. The outcome of interest optimization might unveil additional treatment benefits. Furthermore, testing the biomarker pairs at their optimal cut-off selection might provide the predictive score candidates.Material and methods: 712 plasma 92% and 727 plasma 94% tumor samples of all patients were using Cox model by identifying optimal dichotomization to maximize treatment benefit. A quadrant analysis grouped biomarker pairs into subsets yielded the best clinical benefit. Candidate biomarker score using the nested 2-fold cross-validation method was used to adjust the optimal cut-off selection.Results: Patients with lower VEGF-R1 at optimal cut-off with low IHER2G showed significant improvement in PFS - first line (HR = 0.62; 95% CI: 0.50 to 0.78). The interaction p-value of the biomarker pair was adjusted at 0.0147094.Conclusions: The predictive biomarker is a potential candidate for PFS - first line in patients with advanced gastric cancer treated with Bevacizumab.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"1 1","pages":"402-408"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70475019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Endoscopic management of bleeding ectopic varices: multicentric retrospective case series 内镜下治疗出血异位静脉曲张:多中心回顾性病例系列

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI: 10.5114/pg.2023.130201

Mohamed Ali El-Nady, M. Wahba, O. Ebada, M. Gabr, K. Essam, Abeer Abdellatef, Mohammed Ewid, Hyam Fathy, Mazen Naga, A. Altonbary

引用次数: 0

Evaluation of the effects of the pandemic period on cirrhosis patients. 疫情期间对肝硬化患者影响的评估。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 Epub Date: 2023-09-22 DOI: 10.5114/pg.2023.131393

Rezan Karaali, Ejder Saylav Bora, Firdevs Topal

{"title":"Evaluation of the effects of the pandemic period on cirrhosis patients.","authors":"Rezan Karaali, Ejder Saylav Bora, Firdevs Topal","doi":"10.5114/pg.2023.131393","DOIUrl":"10.5114/pg.2023.131393","url":null,"abstract":"Introduction: Cirrhosis is a common liver disease, which is characterized by life-limiting complications. In cirrhosis, liver ACE2 mRNA levels were 34-times upregulated, ACE2 protein 97-times upregulated, and ACE2 receptors increased in 80% of hepatocytes. Increased ACE2 receptor sensitizes hepatocytes to COVID-19.Aim: To evaluate the applications of cirrhosis patients to the Emergency Department before and after the pandemic.Material and methods: The study was conducted retrospectively in a single centre on cirrhotic patients who applied to the Emergency Department in a 2-year period. The obtained data were compared with the laboratory values of the patients: the severity of cirrhosis, the reasons for applying to the Emergency Department, hospitalization/discharge status, and pre-pandemic and pandemic period values. The mortality of the patients was recorded.Results: The biochemical values, CTP score, and complications of cirrhosis patients deteriorated during the pandemic period, which contributed to the increase in mortality and that the CTP score and its complications worsened, which contributed to the increase in mortality. COVID-19 positivity contributes to the progression of the CTP score, but it is not directly associated with mortality.Conclusions: We think that new treatment protocols should be included in the guidelines to minimize the effects of this type of viral infection on the liver.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"18 3","pages":"320-326"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71485288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0